Bioeq AG Overview
- Headquarters
- Zug, Ch
- Website
- bioeq.ch
- Industry
- Pharmaceutical Manufacturing
- Employees
- 19
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About Bioeq AG
Bioeq AG is a Swiss biopharmaceutical joint venture backed by the leading biosimilar developers Polpharma Biologics Group and Formycon AG and is based in Zug. We license, develop and commercialise a biosimilar, which is a successor product of Lucentis® (ranibizumab), a successful branded biopharmaceutical. We are a young and dynamic company, supported by an international network of experts. Bioeq AG out-licenses its products to established international pharmaceutical companies who ensure local distribution in each territory.
Bioeq AG Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Bioeq AG Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Marcel Schnarwiler | General Manager with International Scope | Zurich, Switzerland |
Email
|
| Gerhard Schmid, Ph.d. | Regulatory Affairs and Biosimilars | Zurich, Switzerland |
Email
|
| Santhana K Lakshminarasimhan | Head - Supply Chain and External | Switzerland |
View
|
| Hannes Teissl | We Care About Biosimilars! | Amsterdam, North Holland, Netherlands |
Email
|
Employees by Management Level
Individual contributor
3 profiles
Manager
1 profile
Compare Similar Companies to Bioeq AG
BeiGene
Biotechnology Research
Acino
Pharmaceutical Manufacturing
Neurocrine Biosciences
Biotechnology Research
MS PHARMA
Pharmaceutical Manufacturing
Polpharma Biologics
Biotechnology Research
Kiniksa Pharmaceuticals
Biotechnology Research
Formycon AG
Biotechnology Research
Polpharma Group
Pharmaceutical Manufacturing
Swiss Pharma International AG
Pharmaceutical Manufacturing
Bio Usawa
Biotechnology Research